Cargando…
Effects of (a Combination of) the Beta(2)-Adrenoceptor Agonist Indacaterol and the Muscarinic Receptor Antagonist Glycopyrrolate on Intrapulmonary Airway Constriction
Expression of bronchodilatory β(2)-adrenoceptors and bronchoconstrictive muscarinic M(3)-receptors alter with airway size. In COPD, (a combination of) β(2)-agonists and muscarinic M(3)-antagonists (anticholinergics) are used as bronchodilators. We studied whether differential receptor expression in...
Autores principales: | Maarsingh, Harm, Oldenburger, Anouk, Han, Bing, Zuidhof, Annet B., Elzinga, Carolina R. S., Timens, Wim, Meurs, Herman, Sopi, Ramadan B., Schmidt, Martina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157597/ https://www.ncbi.nlm.nih.gov/pubmed/34069899 http://dx.doi.org/10.3390/cells10051237 |
Ejemplares similares
-
Small airway hyperresponsiveness in COPD: relationship between structure and function in lung slices
por: Maarsingh, Harm, et al.
Publicado: (2019) -
Anti-Inflammatory Role of the cAMP Effectors Epac and PKA: Implications in Chronic Obstructive Pulmonary Disease
por: Oldenburger, Anouk, et al.
Publicado: (2012) -
Multiple Facets of cAMP Signalling and Physiological Impact: cAMP Compartmentalization in the Lung
por: Oldenburger, Anouk, et al.
Publicado: (2012) -
Long-acting β-adrenoceptor agonists in the management of COPD: focus on indacaterol
por: Beier, Jutta, et al.
Publicado: (2011) -
Cost-effectiveness of twice-daily indacaterol/glycopyrrolate inhalation powder for the treatment of moderate to severe COPD in the US
por: Rajagopalan, Krithika, et al.
Publicado: (2018)